United Therapeutics CEO Martine Rothblatt disposes of common shares worth $4.96 million - UTHR News | RalliesUnited Therapeutics CEO Martine Rothblatt disposes of common shares worth $4.96 million
U
UTHR• Rothblatt exercises options and trust sells shares
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42 on July 29, 2026.
- A family trust sold 9,500 shares the same day at about $518.25 to $525.46.
- The trust’s common stock holdings fell to 324,443 shares following the sales.
- The trust held 246,410 stock options after the exercise.
